SLC5A7 and rheumatic disorder: Studies on rheumatic diseases causing both systemic and local ocular inflammation, such as Behçet’s disease, have reported increased ChT secondary to increased pro-inflammatory cytokine levels, primarily in the acute phase of the disease.